Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico.

Condition:   Multiple Indications Cancer
Intervention:   Other: Non-Interventional
Sponsor:   Bristol-Myers Squibb
Not yet recruiting - verified May 2017

http://ift.tt/2qOpqDZ